HOME >> BIOLOGY >> NEWS
New discovery: If it weren't for this enzyme, decomposing pesticide would take millennia

CHAPEL HILL An enzyme inside a bacterium that grows in the soil of potato fields can -- in a split second -- break down residues of a common powerful pesticide used for killing worms on potatoes, researchers have found.

That may be expensive for farmers but lucky for the environment because University of North Carolina at Chapel Hill scientists have now discovered that if that particular enzyme weren't there, it would take 10,000 years for just half of the widely used pesticide to decompose. And the chemical would remain in the soil of the potato fields where it is now used in colossal amounts, contaminating groundwater and posing a threat to human and animal health.

A report on the unusual discovery appears online in the Proceedings of the National Academy of Sciences Monday (Oct. 24). Authors are Christopher M. Horvat, a UNC chemistry major from Spruce Pine, who plans to become a physician, and Dr. Richard V. Wolfenden, Alumni Distinguished professor of biochemistry and biophysics at the UNC School of Medicine.

"The half-life of the pesticide is longer, by several orders of magnitude, than the half-lives of other known environmental pollutants in water," Wolfenden said. "The half lives of atrazine, aziridine, paraoxon and 1, 2-dichloroethane, for example, are five months, 52 hours, 13 months and 72 years, respectively."

In contrast, the half-life of the potato pesticide residue chloroacrylate -- 10,000 years -- matches the half-life of plutonium-239, the hazardous isotope produced in nuclear power plants, he said.

The bacteria Pseudomonas pavonaceae have evolved in the soil in which the potato pesticide 1, 3-dichloropropene is used and can grow on it as their only source of carbon and energy, the scientist said. The enzyme responsible for degrading the pesticide may have evolved since the chemical's first use on potato fields in 1946. Common names for the agricultural product are Shell D-D and Telone II.

"There is a
'"/>

Contact: David Williamson
rdtokids@email.unc.edu
919-962-8596
University of North Carolina at Chapel Hill
24-Oct-2005


Page: 1 2 3

Related biology news :

1. Biting discovery: MU entomologist finds host of new aquatic insect species in Thailand
2. New discovery: Molecular variation in one gene affects the growth of natural populations
3. The thrill of discovery: Pitt professor reveals how he gets students interested in science
4. The stem cells that werent there
5. Researchers create model of cancer-preventing enzyme, study how it works
6. Elevated inflammatory enzyme, Lp-PLA2, significantly linked to ischemic stroke
7. 100 percent of pregnant women have at least one kind of pesticide in their placenta
8. Premature births may be linked to seasonal levels of pesticides and nitrates in surface water
9. Mayo researcher discovers target site for developing mosquito pesticides
10. Fake pesticides threaten food safety
11. Most widely used organic pesticide requires help to kill

Post Your Comments:
(Date:6/30/2015)... June 30, 2015 To bolster its efforts and ... Corp. announced today the addition of two new team members. ... board advisor and David Raviv will act as ... HYPR Corp.,s commitment to providing the most secure solutions for ... co-founded Layer 7 Technologies, a provider of security and ...
(Date:6/29/2015)... 24, 2015 Research and ... "Latin America Biomedical Sensors Market - Growth, Trends ... The Latin America Biomedical Sensors market is estimated ... 2.04% over the period 2014-2020 The near ... the genetic formulation of each individual. These sensors can ...
(Date:6/25/2015)... -- According to a new market ... Technology, Material (Optical Prism, Piezoelectric, Capacitive & Adhesives), ... & Geography - Global Forecast to 2014 - ... expected to reach $14,500.07 Million by 2020, at ... 76 market Tables and 109 Figures spread through ...
Breaking Biology News(10 mins):HYPR Corp. Expands Biometric Authentication Team with Enterprise All Stars 2HYPR Corp. Expands Biometric Authentication Team with Enterprise All Stars 3Latin America Biomedical Sensors Market Report 2015-2020 2Fingerprint Sensors Market Worth $14,500.07 Million by 2020 2Fingerprint Sensors Market Worth $14,500.07 Million by 2020 3Fingerprint Sensors Market Worth $14,500.07 Million by 2020 4
(Date:7/30/2015)... ... July 30, 2015 , ... The 2015 Market Research Report on ... current state of the global Propanol market with a focus on the Chinese situation. ... Carboclor, Mitsui Chemicals, Oxea, ISU Chemical, Sanofi, Royal Dutch Shell, LG Chem and Zhejiang ...
(Date:7/30/2015)... CITY, Kan. , July 30, 2015 /PRNewswire/ ... ), a pet therapeutics company focused on the ... for companion animals, today announced that its strategic ... from a dose confirmation study of AT-016, an ... Aratana for the treatment of osteoarthritis pain in ...
(Date:7/30/2015)... July 30, 2015 Ascendis Pharma A/S ... applies its innovative TransCon technology to address significant ... from a six-month Phase 2 study to evaluate ... Hormone in 53 treatment-naïve, pre-pubertal children with growth ... extremely pleased with the top-line results from our ...
(Date:7/30/2015)... (PRWEB) , ... July 30, 2015 , ... As part of its 2015 growth plan ... and technical service business units, Whitehouse Laboratories is pleased to announce that ... adjacent to the Container Center of Excellence and will be strictly dedicated to basic USP ...
Breaking Biology Technology:Global Propanol Market Technical Data and Manufacturing Analysis 2020 2Global Propanol Market Technical Data and Manufacturing Analysis 2020 3Aratana Therapeutics Announces Positive Pilot Field Study for AT-016 2Aratana Therapeutics Announces Positive Pilot Field Study for AT-016 3Aratana Therapeutics Announces Positive Pilot Field Study for AT-016 4Aratana Therapeutics Announces Positive Pilot Field Study for AT-016 5Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 2Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 3Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 4Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 5Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 6Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 7Whitehouse Labs Formally Announces Plans to Open a Microbiological Laboratory 2
Cached News: